As MDR Consultants specializing in Medical Devices Rules (IMDR) 2017 and CDSCO compliance, we’ve seen hundreds of foreign manufacturers face unnecessary delays in securing their Form MD-15 Import License. Many applications get stuck for weeks or months — or face outright rejection — due to preventable documentation errors.
Here are the top 5 mistakes we commonly observe in import documentation packages:
1. Incomplete or Improperly Executed Power of Attorney (PoA)
The PoA from the foreign manufacturer to the Indian Authorized Agent (IAA) is a foundational document. Common errors: Not apostilled/legalized properly, missing signatures, outdated PoA, or not executed as a single bound document with the undertaking. Impact: Immediate query or rejection. CDSCO is very strict on this. Fix: Use a PoA template aligned with current CDSCO expectations. Get it notarized, apostilled, and ensure the IAA’s undertaking is attached seamlessly.
2. Incorrect Device Classification or Mismatched Predicate Device
Wrongly classifying a device as Class A/B instead of C/D (or vice versa) leads to submitting inadequate documents and fees. Common errors: Poor predicate analysis or ignoring risk-based rules under IMDR 2017. Impact: Application returned or shifted to a longer review pathway requiring clinical data. Fix: Conduct a thorough classification review with reference to the latest CDSCO lists and rules before submission.
3. Poorly Prepared or Generic Device Master File (DMF) / Plant Master File (PMF)
A generic DMF copied from EU/US dossiers without India-specific details is a frequent red flag. Common errors: Missing risk analysis, incomplete specifications, inadequate sterilization/validation data, or inconsistencies across documents. Impact: Multiple deficiency letters, adding 4–12 weeks per cycle. Fix: Prepare a device-specific DMF/PMF per Part II of the Fourth Schedule, with clear cross-references and harmonized data.
4. Labeling & IFU Non-Compliance
Labels that meet CE or FDA requirements often fail Indian standards. Common errors: Missing import license number placeholder, incorrect manufacturer/importer details, lack of Indian language requirements (where applicable), or non-compliant symbols. Impact: Devices get held at customs even after license approval. Fix: Design labels and IFU strictly as per Chapter VI of IMDR 2017 from day one.
5. Inconsistencies Across Documents or Outdated Certificates
Mismatch in manufacturer name/address, expired ISO 13485, outdated Free Sale Certificate (FSC), or conflicting data between DMF, labels, and certificates. Common errors: Using old versions of documents or not harmonizing everything before SUGAM upload. Impact: Queries, delays, or rejection within the 9-month window. Fix: Implement a final cross-verification checklist and use version control.
Our Proven Solution
In our recent anonymized case study, a foreign manufacturer avoided all these pitfalls and secured approval. The secret? Early expert review, meticulous preparation, and proactive query management on the SUGAM portal.
Key Takeaway: Most delays are not due to product quality but documentation gaps. Investing in professional MDR consulting upfront saves months and significant costs.
Ready to avoid these mistakes? Contact us for a free regulatory gap assessment of your import dossier. We handle end-to-end CDSCO compliance — from IAA appointment and documentation to successful MD-15 grant and post-approval support.
